Cargando…

Regarding the Use of Tamoxifen Post-Oophorectomy to Prevent Hereditary Breast Cancer

Detalles Bibliográficos
Autor principal:	Narod, Steven A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837304/ https://www.ncbi.nlm.nih.gov/pubmed/20223019 http://dx.doi.org/10.1186/1897-4287-4-4-167

Ejemplares similares

The Prevention of Hereditary Breast and Ovarian Cancer: A Personal View
por: Narod, Steven
Publicado: (2004)

Tamoxifen for women at high risk of breast cancer
por: Nazarali, Safia A, et al.
Publicado: (2014)

Oophorectomy for Cancer of the Breast
Publicado: (1900)

Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
por: Metcalfe, Kelly A, et al.
Publicado: (2005)

BRCA Genetic Test and Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer: State-of-the-Art
por: Sekine, Masayuki, et al.
Publicado: (2021)

Oöphorectomy in Cancer
Publicado: (1902)

Oophorectomy in Cancer
Publicado: (1898)

Oophorectomy for Cancer
Publicado: (1897)

Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic type
por: Berchuck, Andrew, et al.
Publicado: (2015)

Dr. Roger Williams on Oöphorectomy for Cancer of the Breast
Publicado: (1902)

Preventing Breast Cancer in High-Risk Women: Is There Still a Role for Oophorectomy?
por: Norquist, Barbara M, et al.
Publicado: (2019)

Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use
por: Kim, Se Ik, et al.
Publicado: (2015)

The mechanism of tamoxifen in breast cancer prevention
por: Yu, F, et al.
Publicado: (2001)

Genetic testing for hereditary breast cancer in Poland: 1998–2022
por: Gronwald, Jacek, et al.
Publicado: (2023)

The Author's Response: Assessment of Breast Cancer Patients’ Knowledge and Decisional Conflict Regarding Tamoxifen Use
por: Kim, Se Ik, et al.
Publicado: (2016)

Changes in Bone Mineral Density After Prophylactic Bilateral Salpingo-Oophorectomy in Carriers of a BRCA Mutation
por: Kotsopoulos, Joanne, et al.
Publicado: (2019)

Ovarian Cancer Incidence Corrected for Oophorectomy
por: Baldwin, Lauren A., et al.
Publicado: (2017)

Theory‐based behavior change intervention to increase uptake of risk‐reducing salpingo‐oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trial
por: Metcalfe, Kelly A., et al.
Publicado: (2023)

Factors associated with the decision to undergo risk-reducing salpingo-oophorectomy among women at high risk for hereditary breast and ovarian cancer: a systematic review
por: Park, Sun-young, et al.
Publicado: (2020)

Prophylactic oophorectomy in Northern Ireland.
por: Fogarty, P.
Publicado: (1991)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk
por: Terry, Mary Beth, et al.
Publicado: (2018)

Tamoxifen Therapy for Recurrent Mucosal Bleeding in Hereditary Hemorrhagic Telangiectasia
por: Yung, Stephanie, et al.
Publicado: (2021)

Early (Prophylactic) Oophorectomy and Adrenalectomy in Carcinoma of the Breast; An Interim Report
por: Patey, D. H.
Publicado: (1960)

Pregnancy after Double Oophorectomy
Publicado: (1892)

What Are the Conditions That Justify Oöphorectomy?
por: Cushing, Clinton
Publicado: (1883)

Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer.
por: Coombes, R. C., et al.
Publicado: (1982)

Tamoxifen Resistance in Breast Cancer
por: Chang, Minsun
Publicado: (2012)

Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer
por: Nichols, Hazel B, et al.
Publicado: (2013)

Risk of Fracture After Bilateral Oophorectomy
por: Hueg, Trine K, et al.
Publicado: (2023)

TUBectomy with delayed oophorectomy as an alternative to risk-reducing salpingo-oophorectomy in high-risk women to assess the safety of prevention: the TUBA-WISP II study protocol
por: Steenbeek, Miranda P, et al.
Publicado: (2023)

Adjuvant tamoxifen for early breast cancer.
por: Smith, I.
Publicado: (1988)

Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers
por: Menkiszak, Janusz, et al.
Publicado: (2016)

Risk-reducing salpingo-oophorectomy among Chinese women at increased risk of breast and ovarian cancer
por: Feng, Zheng, et al.
Publicado: (2023)

Breast cancer prevention in women with a BRCA1 or BRCA2 mutation
por: Metcalfe, Kelly A, et al.
Publicado: (2007)

Proceedings: Prediction of response of disseminated breast cancer to andrenalectomy and oophorectomy using computer aided evaluation of clinical presentation.
por: Leaper, D. J., et al.
Publicado: (1974)

The effect of anastrozole on the pharmacokinetics of tamoxifen in post-menopausal women with early breast cancer
por: Dowsett, M, et al.
Publicado: (1999)

Tamoxifen: molecular basis of use in cancer treatment and prevention
por: Jarman, M
Publicado: (1996)

Hysterectomy, Oophorectomy, Estrogen, and the Risk of Dementia
por: Rocca, Walter A., et al.
Publicado: (2012)

Fertility after oophorectomy due to torsion
por: Al-Turki, Haifa A.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rfkl8vgrg67feb86gd6mje6f64